📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Stage Cell Therapeutics

1.1 - Company Overview

Stage Cell Therapeutics Logo

Stage Cell Therapeutics

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a proprietary Streptamer platform enabling rapid development and production of safe and efficient cell therapeutics; privately held biotech active since 2005.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Stage Cell Therapeutics

Antiva Biosciences Logo

Antiva Biosciences

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics targeting diseases caused by HPV infection, including ABI-2280, a topical prodrug designed to treat high-grade cervical intraepithelial neoplasias (HSIL, CIN 2,3) and high-risk HPV infections by blocking HPV replication and inducing apoptosis in infected cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Antiva Biosciences company profile →
Pairwise Logo

Pairwise

HQ: United States Website
  • Description: Provider of plant-based innovation via the Fulcrum platform to accelerate production systems, developing seedless blackberries, black raspberries, red raspberries, and pitless cherries with year-round availability, and offering the Good Food for All program to expand access to fruits and vegetables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pairwise company profile →
Orna Therapeutics Logo

Orna Therapeutics

HQ: United States Website
  • Description: Provider of engineered circular RNA therapeutics and tools: isCAR therapy using oRNA and proprietary LNPs to modify immune cells for tumor control without lymphodepletion; oRNA-based dystrophin replacement via non-viral delivery to liver and muscle; next-generation vaccines with Merck using oRNA/LNP; and FoRCE for high-throughput oRNA sequence evaluation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orna Therapeutics company profile →
PlasmidFactory Logo

PlasmidFactory

HQ: Germany Website
  • Description: Provider of contract manufacturing for plasmid and minicircle DNA, serving cancer research, gene and cell therapy, CAR T-cell development, and vaccination. Offerings include plasmid DNA production, minicircle DNA vectors, capillary gel electrophoresis quality control, GMP-compliant long-term DNA storage, and R&D services in plasmid and minicircle DNA technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PlasmidFactory company profile →
Synlogic Logo

Synlogic

HQ: United States Website
  • Description: Provider of synthetic biotic medicines designed to perform metabolic functions to treat diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synlogic company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Stage Cell Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Stage Cell Therapeutics

2.2 - Growth funds investing in similar companies to Stage Cell Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Stage Cell Therapeutics

4.2 - Public trading comparable groups for Stage Cell Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Stage Cell Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Stage Cell Therapeutics

What does Stage Cell Therapeutics do?

Stage Cell Therapeutics is a provider of a proprietary Streptamer platform enabling rapid development and production of safe and efficient cell therapeutics; privately held biotech active since 2005.

Who are Stage Cell Therapeutics's competitors?

Stage Cell Therapeutics's competitors and similar companies include Antiva Biosciences, Pairwise, Orna Therapeutics, PlasmidFactory, and Synlogic.

Where is Stage Cell Therapeutics headquartered?

Stage Cell Therapeutics is headquartered in Germany.

How many employees does Stage Cell Therapeutics have?

Stage Cell Therapeutics has 1,000 employees 🔒.

When was Stage Cell Therapeutics founded?

Stage Cell Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Stage Cell Therapeutics in?

Stage Cell Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Stage Cell Therapeutics

Who are the top strategic acquirers in Stage Cell Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Stage Cell Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Stage Cell Therapeutics?

Top strategic M&A buyers groups and sectors for Stage Cell Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Stage Cell Therapeutics's sector and industry vertical

Which are the top PE firms investing in Stage Cell Therapeutics's sector and industry vertical?

Top PE firms investing in Stage Cell Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Stage Cell Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Stage Cell Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Stage Cell Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Stage Cell Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Stage Cell Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Stage Cell Therapeutics?

The key public trading comparables and valuation benchmarks for Stage Cell Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Stage Cell Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Stage Cell Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Stage Cell Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Stage Cell Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Stage Cell Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Stage Cell Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Stage Cell Therapeutics